Fig 1.
Data sources and date coverage.
NSWCR: New South Wales Cancer Registry; MBS: Medicare Benefits Schedule; PBS: Pharmaceutical Benefits Scheme; RBDM: Registry of Births, Deaths and Marriages. Reproduced from reference [5].
Fig 2.
Cohort selection flow diagram.
Table 1.
Sociodemographic, diagnosis and treatment characteristics of colon and rectal cancer cases diagnosed 2006–2013 in the 45 and Up Study.
Table 2.
Mean excess costs for colon and rectal cases diagnosed 2006–2013 in the 45 and Up Study, by phase of care, source of costs and disease stage.
Fig 3.
Multivariable adjusted excess costs of colon and rectal cancer in the initial phase of care.
Notes: The dashed vertical line is the adjusted excess cost for a case in the reference category for all characteristics (i.e. $43,077 for colon cancer cases and $44,571 for rectal). For each category of a characteristic, the estimate shown reflects the adjusted excess cost for a case with all other characteristics in the reference category. To allow regression with non-negative values, the models were constructed using an offset of +$50,000; this offset was then deducted to obtain the adjusted estimates shown in the figure.
Fig 4.
Multivariable adjusted excess hospital days for colon and rectal cancer in the initial phase of care.
Notes: The dashed vertical line is the adjusted excess hospital days for a case in the reference category for all characteristics (i.e. 11 days for colon cancer and 12 days for rectal). For each category of a characteristic, the estimate shown reflects the adjusted excess days for a case with all other characteristics in the reference category. To allow regression with non-negative values, the models were constructed using an offset of +50 days; this offset was then deducted to obtain the adjusted estimates shown in the figure.
Table 3.
Mean excess hospital days for colon and rectal cases diagnosed 2006–2013 in the 45 and Up Study, by phase of care and disease stage.